Antimicrobial Resistance in Canada: An Update on Activities of the Canadian Committee on Antibiotic Resistance

John Conly

doi:10.1155/2001/364032

Abstract

This article is the first in a planned series of semi-annual updates, intended to provide readers with up-to-date information on antibiotic resistance in Canada and on the many current activities designed to address the problem. This information is provided by the Canadian Committee on Antibiotic Resistance (CCAR), a national organization that has a mandate to coordinate activities designed to address the growing problem of antibiotic resistance in Canada.

Highlights

Antibiotic resistance has become an issue of increasing importance in recent years as more patients become infected with resistant pathogens, and as the public, the media and health care professionals become aware of the significant economic and social consequences of these diseases
In November 1999, Health Canada committed to three years of funding to support the activities of Canadian Committee on Antibiotic Resistance (CCAR), which is charged with facilitating implementation of the Action Plan
Associate membership is available to individuals who are actively engaged in issues related to antibiotic resistance

Summary

Introduction

Antibiotic resistance has become an issue of increasing importance in recent years as more patients become infected with resistant pathogens, and as the public, the media and health care professionals become aware of the significant economic and social consequences of these diseases. CCAR In 1997, Health Canada convened a consensus conference on antibiotic resistance to develop a coordinated national plan to address this problem. In November 1999, Health Canada committed to three years of funding to support the activities of CCAR, which is charged with facilitating implementation of the Action Plan.

Results

Conclusion